Electromagnetic Navigation Bronchoscopy Shows Positive Response In Lung Cancer Study

An analysis of 12-month results from NAVIGATE, the largest, prospective, multicenter trial designed to evaluate outcomes following electromagnetic navigation bronchoscopy™ (ENB™) procedures using Medtronic's superDimension™ navigation system, shows positive...

Scientists Discover Possible way to Make Resistant Melanomas Susceptible to Immunotherapy

Researchers at the Ludwig Cancer Research Institute,  an international community of scientists focused on cancer research, with headquarters in New York City, NY and Zürich, Switzerland, have uncovered a...

Minimally Invasive Endoscopy Tool may Change Treatment for Pancreatic Cancer Patients

A minimally invasive treatment option may change treatment options for patients with pancreatic cancer. The development of significantly more effective treatment options is possible as a result of an...

Dr. Brawley Goes to Baltimore…and Washington

The latest chapter in Otis W. Brawley, MD’s illustrious career in cancer prevention and control commenced earlier this month when he began his tenure as a Bloomberg Distinguished Professor...

Study Shows How Molecular Profiling may Help Catch Lung Cancer Early, Leading to New...

The world's first genetic sequencing of precancerous lung lesions, referred to as lung carcinoma in situ (CIS) are the preinvasive precursor to squamous cell carcinoma and could pave the...

FDA Approves Samsung Bioepis’ First Oncology Biosimilar Trastuzumab-dttb

The U.S. Food and Drug Administration (FDA) has approved trastuzumab-dttb (Ontruzant®; Samsung Bioepis) a biosimilar referencing* trastuzumab (Herceptin®; Genentech/Roche), for adjuvant treatment of HER2-overexpressing (ER/PR-negative o with high risk**)...